Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

Abstract

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 (N Engl J Med 2020;383:2041-2052). The report as published did not provide accurate and complete information on the frequency and duration of previous use of hydroxychloroquine or azithromycin among the trial participants. In the Participants subsection of Methods (page 2), the first sentence should have begun, "We enrolled patients who were either actively screened by the trial team or referred to us who were 18 years of age or older and had been hospitalized horizontal ellipsis ," rather than "The trial included consecutive patients who were 18 years of age or older and who had been hospitalized horizontal ellipsis ." In the second sentence, the phrase "previous use of . . .